Showing results (11-20 of 333) with videos related to
Sort By:
Pageof 34
Advances in Experimental Medicine and Biology|May 29, 2019
Ovarian Cancer Stem Cell HeterogeneityJiri Hatina, Maximilian Boesch, Sieghart Sopper, et al.Critical Reviews in Oncology/Hematology|July 10, 2020
Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)Finn Mildner, Sieghart Sopper, Arno Amann, et al.Oncoscience|May 27, 2016
High prevalence of side population in human cancer cell linesMaximilian Boesch, Alain G Zeimet, Heidi Fiegl, et al.Pathology Oncology Research : POR|January 1, 1997
The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus InfectionChristian Jassoy, Martin Heinkelein, Sieghart SopperJournal of Cancer Research and Clinical Oncology|August 8, 2018
Evaluation of Vav3.1 as prognostic marker in endometrial cancerMaximilian Boesch, Sieghart Sopper, Christian Marth, et al.International Journal of Cancer|December 5, 2019
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcomeDominik Wolf, Heidi Fiegl, Alain G Zeimet, et al.Oncotarget|September 13, 2014
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristicsMaximilian Boesch, Alain G Zeimet, Daniel Reimer, et al.International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.Diabetes|September 14, 2011
Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathyKathrin Eller, Alexander Kirsch, Anna M Wolf, et al.Molecular Immunology|October 19, 2004
HIV-infection of the central nervous system: the tightrope walk of innate immunityCornelia Speth, Manfred P Dierich, Sieghart SopperPageof 34